Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prevention of COVID-19 Progression Through Early Administration of Inhaled Nitric Oxide.

NCT04388683 is registered in ClinicalTrials.gov with Tufts Medical Center as lead sponsor.

NCT NCT04388683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04388683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prevention of COVID-19 Progression Through Early Administration of Inhaled Nitric Oxide.
Lead sponsor
Tufts Medical Center
Phase
Phase 2
Overall status
Terminated
Start date
May 12, 2020
Completion date
November 23, 2020
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid-19